Market Cap 601.19M
Revenue (ttm) 0.00
Net Income (ttm) -62.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,147,000
Avg Vol 1,413,852
Day's Range N/A - N/A
Shares Out 74.68M
Stochastic %K 93%
Beta 0.70
Analysts Strong Sell
Price Target $15.33

Company Profile

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The company's lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell atopic dermatitis, asthma, psori...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 900 4520
Address:
901 Gateway Boulevard, Third Floor, South San Francisco, United States
BEATOFtheMARKET
BEATOFtheMARKET Jan. 18 at 12:55 AM
0 · Reply
AstroGleam
AstroGleam Jan. 18 at 12:24 AM
”@CoralSharkie on a different level 🧠 ”Real game shared and it doesn’t cost you anything but a click Follow him💎 Straight gems 🌟 heavy value. $AGIG $CPSH $CRVS $RCEL <> On close watch..
0 · Reply
VISIUM
VISIUM Jan. 17 at 9:26 PM
$CRVS what time do you think Richard Miller will be waking up on Monday?
1 · Reply
MedicalDoctorInvestor
MedicalDoctorInvestor Jan. 17 at 8:32 PM
$CRVS 🚨. The idiocy is increasing. Morons are in control. Be safe out there.
1 · Reply
TrumpthePedo
TrumpthePedo Jan. 17 at 7:35 PM
$CRVS damn, wish I got in on Friday
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 17 at 6:48 PM
$CRVS AD is a 100B market. If CRVS shows better than Dupi efficacy while being safe. It'll take a big market share. That is on AD alone. Not including ALPS and PTCL and other indications. CRVS is going to be absurdly massive
3 · Reply
RandomInvestor777
RandomInvestor777 Jan. 17 at 6:40 PM
$CRVS KYMR with a 4 week data open label with similar N. gained 2.5 billion market cap (33-36 share price for CRVS). Why wouldn't CRVS, which showed far better data in cohort 3 and will likely show the same or even better in cohort 4 With placebo + blinded (to patients/investigators) not go up massively?
1 · Reply
dwsrph1
dwsrph1 Jan. 17 at 6:22 PM
$CRVS I think smell my ass maybe a democrat? He asks questions but has no answers???
1 · Reply
outlawinvestor1
outlawinvestor1 Jan. 17 at 6:14 PM
0 · Reply
outlawinvestor1
outlawinvestor1 Jan. 17 at 6:06 PM
1 · Reply
Latest News on CRVS
Why Is Corvus Pharmaceuticals Stock Soaring On Friday?

May 9, 2025, 11:57 AM EDT - 9 months ago

Why Is Corvus Pharmaceuticals Stock Soaring On Friday?


Corvus Pharmaceuticals: Now At Cruising Altitude

Mar 28, 2025, 9:29 AM EDT - 10 months ago

Corvus Pharmaceuticals: Now At Cruising Altitude


Corvus Pharmaceuticals: The Market Likes The Story

Nov 13, 2024, 1:18 PM EST - 1 year ago

Corvus Pharmaceuticals: The Market Likes The Story


Corvus Pharmaceuticals Is Ready To Take Flight

Jun 20, 2024, 6:53 AM EDT - 1 year ago

Corvus Pharmaceuticals Is Ready To Take Flight


BEATOFtheMARKET
BEATOFtheMARKET Jan. 18 at 12:55 AM
0 · Reply
AstroGleam
AstroGleam Jan. 18 at 12:24 AM
”@CoralSharkie on a different level 🧠 ”Real game shared and it doesn’t cost you anything but a click Follow him💎 Straight gems 🌟 heavy value. $AGIG $CPSH $CRVS $RCEL <> On close watch..
0 · Reply
VISIUM
VISIUM Jan. 17 at 9:26 PM
$CRVS what time do you think Richard Miller will be waking up on Monday?
1 · Reply
MedicalDoctorInvestor
MedicalDoctorInvestor Jan. 17 at 8:32 PM
$CRVS 🚨. The idiocy is increasing. Morons are in control. Be safe out there.
1 · Reply
TrumpthePedo
TrumpthePedo Jan. 17 at 7:35 PM
$CRVS damn, wish I got in on Friday
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 17 at 6:48 PM
$CRVS AD is a 100B market. If CRVS shows better than Dupi efficacy while being safe. It'll take a big market share. That is on AD alone. Not including ALPS and PTCL and other indications. CRVS is going to be absurdly massive
3 · Reply
RandomInvestor777
RandomInvestor777 Jan. 17 at 6:40 PM
$CRVS KYMR with a 4 week data open label with similar N. gained 2.5 billion market cap (33-36 share price for CRVS). Why wouldn't CRVS, which showed far better data in cohort 3 and will likely show the same or even better in cohort 4 With placebo + blinded (to patients/investigators) not go up massively?
1 · Reply
dwsrph1
dwsrph1 Jan. 17 at 6:22 PM
$CRVS I think smell my ass maybe a democrat? He asks questions but has no answers???
1 · Reply
outlawinvestor1
outlawinvestor1 Jan. 17 at 6:14 PM
0 · Reply
outlawinvestor1
outlawinvestor1 Jan. 17 at 6:06 PM
1 · Reply
dwsrph1
dwsrph1 Jan. 17 at 6:01 PM
$CRVS anyone here no smell my ass?
1 · Reply
tradingjunk321
tradingjunk321 Jan. 17 at 5:52 PM
$CRVS Moore info!
1 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 17 at 4:34 PM
$ARKK Looks like it’s eyeing a breakout. Right at two key resistance zones — if it clears, a clean swing trade setup could be in play for a strong move higher. Watch this closely. $ARKQ $CRVS If this helps, tap @QuantitativeTrading_
0 · Reply
tradingjunk321
tradingjunk321 Jan. 17 at 4:14 PM
$CRVS Ok, put first order in 😂 I'll have many Moore every $10 up
0 · Reply
Smellmahass
Smellmahass Jan. 17 at 3:34 PM
$CRVS I hope it doesnt move much until open on Tuesday.
1 · Reply
biotech_loser
biotech_loser Jan. 17 at 3:28 PM
$CRVS they want the market’s reaction or they could have released even on Monday, though it’s MLK day but not everyone is off. They could have released it next Friday too, but they want the full week of market reacting.
0 · Reply
dixiebull
dixiebull Jan. 17 at 3:16 PM
$IBRX strong move to 6.47, see if 6 holds for 6.50 break to 7 $CRVS see if 8 holds ow for a move to 10 $FIGR if 75 can break again then 76.50 to 78 $CRML if 17.50 can hold then 18 to 20 $TNMG we want 3 to hold for a move to 4 and possibly 5 (for day trade)
2 · Reply
tradingjunk321
tradingjunk321 Jan. 17 at 2:19 PM
$CRVS Moore
2 · Reply
JFais
JFais Jan. 17 at 1:48 PM
Per your request: EV gap for $CRVS vs $KYMR $APGE $NKTR All in atopic dermatitis space, though obviously far from being apples to apples (more like apples to fruit loops). Still fun re point of comparison
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Jan. 17 at 11:05 AM
$CRVS IMHO, Tuesday’s pre-market conference call signals the team believes they have compelling data. They intentionally skipped announcing during JPM, likely to make sure all eyes are on them come Tuesday morning. If this helps, tap @QuantitativeTrading_ this one is shaping up to be intriguing.
0 · Reply
tradingjunk321
tradingjunk321 Jan. 17 at 8:53 AM
$CRVS 72 hours and 7 minutes Moore to go!
2 · Reply
RandomInvestor777
RandomInvestor777 Jan. 17 at 8:22 AM
$CRVS long weekend wait but it will be worth
1 · Reply